5 years ago

Chemobacterial Synthesis of a Sialyl-Tn Cyclopeptide Vaccine Candidate

Chemobacterial Synthesis of a Sialyl-Tn Cyclopeptide Vaccine Candidate
Sébastien Fort, Carlo Pifferi, Michele Fiore, Eric Samain, Bernard Priem, Audrey Le Gouëllec, Olivier Renaudet, Emeline Richard
A conjugatable form of the tumour-associated carbohydrate antigen sialyl-Tn (Neu5Ac-α-2,6-GalNAc) was efficiently produced in Escherichia coli. Metabolically engineered E. coli strains overexpressing the 6-sialyltransferase gene of Photobacterium sp. and CMP-Neu5Ac synthetase genes of Neisseria meningitidis were cultivated at high density in the presence of GalNAc-α-propargyl as the exogenous acceptor. The target disaccharides, which were produced on the scale of several hundreds of milligrams, were then conjugated by using copper(I)-catalysed azide–alkyne cycloaddition click chemistry to a fully synthetic and immunogenic scaffold with the aim to create a candidate anticancer vaccine. Four sialyl-Tn epitopes were introduced on the upper face of an azido-functionalised multivalent cyclopeptide scaffold, the lower face of which was previously modified by an immunogenic polypeptide, PADRE. The ability of the resulting glycoconjugate to interact with oncofoetal sialyl-Tn monoclonal antibodies was confirmed in ELISA assays. Call for immunity: A sialyl-Tn (STn) cyclopeptide scaffold bearing the helper T-cell peptide epitope (PADRE) is synthesised. Although the resulting glycoconjugate lacks the native MUC1 peptide sequence, its ability to interact with sialyl-Tn monoclonal antibodies is confirmed in ELISA assays. The availability of sialylated carbohydrate antigens opens up possibilities for the development of a new generation of synthetic antitumour vaccines.

Publisher URL: http://onlinelibrary.wiley.com/resolve/doi

DOI: 10.1002/cbic.201700240

You might also like
Discover & Discuss Important Research

Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.